DS stage I plasma cell myeloma

Clinical trials for DS stage I plasma cell myeloma explained in plain language.

Never miss a new study

Get alerted when new DS stage I plasma cell myeloma trials appear

Sign up with your email to follow new studies for DS stage I plasma cell myeloma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New drug combo shows promise for aggressive myeloma

Disease control Completed

This study tested adding elotuzumab to a standard three-drug combination (bortezomib, lenalidomide, dexamethasone) for people newly diagnosed with high-risk multiple myeloma, a blood cancer that tends to come back quickly. The goal was to find the safest dose of elotuzumab and se…

Matched conditions: DS STAGE I PLASMA CELL MYELOMA

Phase 1/2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control

Last updated Jun 27, 2026 12:24 UTC

DS stage I plasma cell myeloma

Get alerted when new DS stage I plasma cell myeloma trials appear

New drug combo shows promise for aggressive myeloma